Search results
- 4.1900Add to watchlist-0.5200 (-11.04%)At close: Fri. May 24, 2024 4:00 PM EDT · Nasdaq Real Time Price (USD) · Market closed
- Open4.7100High4.7100Low4.1600
- Mkt Cap63.8MP/E (TTM)N/ADiv & YieldN/A & N/A
- Prev. Close4.710052 Wk. Low2.240052 Wk. High9.1000
Related stocks
1.3800. +6.15%. Find the latest Affimed N.V. (AFMD) stock quote, history, news and other vital information to help you with your stock trading and investing.
- Chart
Interactive Chart for Affimed N.V. (AFMD), analyze all the...
- Conversations
Find the latest Affimed N.V. (AFMD) stock discussion in...
- Holders
Find out the direct holders, institutional holders and...
- Chart
Get the latest Affimed NV (AFMD) real-time quote, historical performance, charts, and other financial information to help you make more informed trading and investment decisions.
6 days ago · Affimed is a clinical-stage immuno-oncology company that develops novel therapies for cancer. See its latest stock price, financial results, news, analysis, and chart on Stock Analysis.
People also ask
Is afmd a good stock to buy?
Where is afmd headquartered?
Is affimed NV (afmd) a good stock to buy?
When does afmd (afmd) stock close?
4 days ago · Affimed N.V. is a biotechnology company developing immunotherapies for cancer and autoimmune diseases. See its stock quote, performance, financials, analyst ratings, news and more on MarketWatch.
May 17, 2024 · Get the latest stock price, bid and ask, market cap, and news for Affimed N.V. (AFMD), a biopharmaceutical company developing immunotherapies for cancer and autoimmune diseases. See historical data, trends, and insights for informed trading and investment decisions.
A high-level overview of Affimed N.V. (AFMD) stock. Stay up to date on the latest stock price, chart, news, analysis, fundamentals, trading and investment tools.
View the latest Affimed N.V. (AFMD) stock price, news, historical charts, analyst ratings and financial information from WSJ.